Ultima-Epithalon 50mg

Manufacturer: Ultima Pharmaceuticals

Pharmaceutical name: Epithalon Acetate

Pack: 1 vial (50 mg)

Epithalon is a synthetic tetra-peptide derived from Epithalamin (epithalon tetra), which is created naturally by the brain's pineal gland. This tetra-peptide consists of four amino acids: alanine, glutamic acid, aspartic acid, and glycine, and it has demonstrated various beneficial biological effects in both animal and human research. Prolonged administration of Epithalamin has been linked to an increase in the average and maximum life spans of aging rats, mice, and fruit flies. In human cells, Epithalon enhances telomerase enzyme activity and promotes telomere elongation, possibly through the reactivation of the telomerase gene. Telomerase works to lengthen the DNA in human cells, effectively making them biologically younger, which opens up the potential for extending the overall lifespan of cell populations and the body as a whole. A 12-month study involving patients with accelerated aging who received treatment with Epithalon indicated that the peptide helped normalize metabolism and improved various metabolic system conditions.

 

The peptide also demonstrated the ability to lower serum insulin and fatty acid levels in rabbits while enhancing glucose tolerance in these animals. Epithalon encourages immune function by increasing the production of antibody-producing cells that combat infections. Moreover, Epithalon acts as a powerful antioxidant, promoting the production of several antioxidant enzymes within the body to enhance its defense against oxidative stress. Overall, findings indicate a high efficacy of epithalamin therapy in mitigating age-related diseases, such as different cancers, metabolic syndromes, and cardiovascular issues. These studies suggest that the peptide could help slow disease progression and extend human lifespan.

 

Epithalon should be administered via subcutaneous or intramuscular injection for optimal effectiveness, as oral ingestion leads to its degradation. A dose of 5 mg of Epithalon can be injected either once or twice daily, preferably in the morning and afternoon if taken twice. It is recommended to administer Epithalon for cycles of 20 days followed by a break of four to six months. Once reconstituted in BAC water, Epithalon remains stable for a complete 20-day treatment cycle if stored at 4-8°C. After this duration, the peptide may lose potency and should be discarded.

 

Long-term human clinical trials have reported no adverse effects associated with Epithalon. In these studies, the peptide was administered intramuscularly at 10 mg in 2 ml saline every three days, with a six-month break between treatment courses.